Phase 3 study of EPOCH to maintain hemoglobin levels in hemodialysis patients
Phase 3
- Conditions
- Renal anemia
- Registration Number
- JPRN-jRCT2080220011
- Lead Sponsor
- Chugai Pharmaceutical Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
1.20 years - 80 years of age
2.hemoglobin between 9.0 g/dl to 12.0 g/dl
3.serum ferritin level and over 100 ng/ml or transferrin saturation and over 20%
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Efficacy and safety
- Secondary Outcome Measures
Name Time Method